M Oto1, C Espie, A Pelosi, M Selkirk, R Duncan. 1. Southern General Hospital, Institute of Neurological Sciences, 1345 Govan Road, Glasgow G51 4TF, UK. meritxelloto@hotmail.com
Abstract
BACKGROUND: To determine whether withdrawal of anticonvulsant drugs (AED) can be carried out safely in patients with non-epileptic seizures (NES). METHODS: Prospective evaluation of safety and outcome in 78 patients with NES who satisfied a standardised set of criteria for excluding the diagnosis of coexisting or underlying epilepsy. FINDINGS: The patients were taking from one to three AED. Sixty four patients were withdrawn as outpatients, 14 as inpatients. Five patients stopped their drugs abruptly, and two had AED restarted and had to be withdrawn again. Otherwise all patients adhered to withdrawal schedules. A new type of attack in addition to NES was seen in three patients (complex partial seizures in all three cases). NES frequency declined in the group as a whole over the period of the study (follow up 6-12 months) in all individuals except for eight patients in whom there was a transient increase. Fourteen patients reported new physical symptoms after withdrawal; however, no serious adverse events were reported. CONCLUSIONS: With appropriate diagnostic investigation and surveillance during follow up withdrawal of AED can be achieved safely in patients with NES.
BACKGROUND: To determine whether withdrawal of anticonvulsant drugs (AED) can be carried out safely in patients with non-epilepticseizures (NES). METHODS: Prospective evaluation of safety and outcome in 78 patients with NES who satisfied a standardised set of criteria for excluding the diagnosis of coexisting or underlying epilepsy. FINDINGS: The patients were taking from one to three AED. Sixty four patients were withdrawn as outpatients, 14 as inpatients. Five patients stopped their drugs abruptly, and two had AED restarted and had to be withdrawn again. Otherwise all patients adhered to withdrawal schedules. A new type of attack in addition to NES was seen in three patients (complex partial seizures in all three cases). NES frequency declined in the group as a whole over the period of the study (follow up 6-12 months) in all individuals except for eight patients in whom there was a transient increase. Fourteen patients reported new physical symptoms after withdrawal; however, no serious adverse events were reported. CONCLUSIONS: With appropriate diagnostic investigation and surveillance during follow up withdrawal of AED can be achieved safely in patients with NES.
Authors: Karina Bennett; Clare Diamond; Ingrid Hoeritzauer; Paula Gardiner; Laura McWhirter; Alan Carson; Jon Stone Journal: Clin Med (Lond) Date: 2021-01 Impact factor: 2.659
Authors: L H Goldstein; T Chalder; C Chigwedere; M R Khondoker; J Moriarty; B K Toone; J D C Mellers Journal: Neurology Date: 2010-06-15 Impact factor: 9.910
Authors: Mark Hallett; Selma Aybek; Barbara A Dworetzky; Laura McWhirter; Jeffrey P Staab; Jon Stone Journal: Lancet Neurol Date: 2022-04-14 Impact factor: 59.935
Authors: W Curt LaFrance; Kenneth Alper; Debra Babcock; John J Barry; Selim Benbadis; Rochelle Caplan; John Gates; Margaret Jacobs; Andres Kanner; Roy Martin; Lynn Rundhaugen; Randy Stewart; Christina Vert Journal: Epilepsy Behav Date: 2006-03-15 Impact factor: 2.937
Authors: Kurt Fritzsche; Kathrin Baumann; Katrin Götz-Trabert; Andreas Schulze-Bonhage Journal: Dtsch Arztebl Int Date: 2013-04-12 Impact factor: 5.594
Authors: Bastian Volbers; Katrin Walther; Katrin Kurzbuch; Laura Erdmann; Stephanie Gollwitzer; Johannes D Lang; Müjgan Dogan Onugoren; Michael Schwarz; Stefan Schwab; Hajo M Hamer Journal: Brain Behav Date: 2022-04-12 Impact factor: 3.405